AEVIS VICTORIA SA / Key word(s): 9 Month figures Ad hoc announcement pursuant to Art. 53 LR Fribourg, 12 November 2024 AEVIS VICTORIA SA (AEVS.SW) – Continued organic growth in the third quarter of 2024 AEVIS VICTORIA SA (AEVIS) achieved total revenues of CHF 761.0 million as at 30 September 2024, an increase of 7.1% compared to CHF 710.2 million in 2023. On a comparable basis, organic revenue growth was 6.0%, reflecting solid performance in the healthcare, hospitality and real estate segments. Swiss Medical Network SA, the group’s healthcare segment, generated total revenues of CHF 594.9 million as at 30 September 2024, an increase of 5.1% over the prior year. This includes organic growth of 3.7%, supported by sustained demand for specialized healthcare services. MRH Switzerland AG (formerly Victoria Jungfrau AG), the group’s hospitality division, achieved total revenues of CHF 151.6 million, an increase of 12.4% compared to the first nine months of 2023. Organic growth was 11.7%, driven by key destinations such as Interlaken and Zermatt. The real estate segment also posted strong growth with total revenues of CHF 24.0 million, a 24.8% increase from 2023. This segment continues to benefit from the appreciation of the group’s strategic real estate assets. For further information: AEVIS VICTORIA SA - Investing for a better life End of Inside Information |
2027275 12-Nov-2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.